BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS - US09075A1088 - Common Stock
7.22 USD
-0.18 (-2.43%)
7.22 USD
0 (0%)
Taking everything into account, BVS scores 4 out of 10 in our fundamental rating. BVS was compared to 190 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BVS while its profitability can be described as average. BVS is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
BVS had positive earnings in the past year.
BVS had a positive operating cash flow in the past year.
In multiple years BVS reported negative net income over the last 5 years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.02%, BVS is in the better half of the industry, outperforming 71.05% of the companies in the same industry.
BVS's Return On Equity of -0.10% is fine compared to the rest of the industry. BVS outperforms 71.58% of its industry peers.
BVS's Return On Invested Capital of 6.08% is amongst the best of the industry. BVS outperforms 81.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.02% | ||
| ROE | -0.1% | ||
| ROIC | 6.08% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a better Operating Margin (7.11%) than 74.21% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
BVS's Gross Margin of 67.60% is fine compared to the rest of the industry. BVS outperforms 74.21% of its industry peers.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 67.6% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
BVS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BVS has more shares outstanding
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
BVS has an Altman-Z score of 1.11. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BVS (1.11) is comparable to the rest of the industry.
The Debt to FCF ratio of BVS is 10.30, which is on the high side as it means it would take BVS, 10.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BVS (10.30) is better than 73.16% of its industry peers.
BVS has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.90, BVS is not doing good in the industry: 83.68% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 10.3 | ||
| Altman-Z | 1.11 |
ROIC/WACC0.71
WACC8.57%
2.3 Liquidity
BVS has a Current Ratio of 1.48. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.48, BVS is not doing good in the industry: 75.79% of the companies in the same industry are doing better.
BVS has a Quick Ratio of 1.48. This is a bad value and indicates that BVS is not financially healthy enough and could expect problems in meeting its short term obligations.
BVS has a Quick ratio of 0.96. This is in the lower half of the industry: BVS underperforms 78.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.58% over the past year.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 5.07%.
BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
Revenue 1Y (TTM)5.07%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
3.2 Future
Based on estimates for the next years, BVS will show a very strong growth in Earnings Per Share. The EPS will grow by 23.03% on average per year.
BVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.09% yearly.
EPS Next Y38.25%
EPS Next 2Y32.75%
EPS Next 3Y23.03%
EPS Next 5YN/A
Revenue Next Year0.06%
Revenue Next 2Y3.4%
Revenue Next 3Y4.09%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.44 indicates a correct valuation of BVS.
Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 88.42% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (26.90), we can say BVS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 8.72, the valuation of BVS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 94.21% of the companies listed in the same industry.
BVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.52.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.44 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 90.53% of the companies listed in the same industry.
BVS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BVS is cheaper than 88.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.51 | ||
| EV/EBITDA | 10.49 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BVS's earnings are expected to grow with 23.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y32.75%
EPS Next 3Y23.03%
5. Dividend
5.1 Amount
No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.22
-0.18 (-2.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners72.05%
Inst Owner Change2.29%
Ins Owners2.56%
Ins Owner Change3.64%
Market Cap596.95M
Analysts77.5
Price Target14.28 (97.78%)
Short Float %3.2%
Short Ratio3.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)119.26%
Min EPS beat(2)-0.99%
Max EPS beat(2)239.51%
EPS beat(4)3
Avg EPS beat(4)103.69%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)172.93%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)0.07%
Revenue beat(4)3
Avg Revenue beat(4)2.02%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)4.79%
Revenue beat(8)7
Avg Revenue beat(8)4.23%
Revenue beat(12)9
Avg Revenue beat(12)1.98%
Revenue beat(16)11
Avg Revenue beat(16)1.72%
PT rev (1m)0%
PT rev (3m)-6.67%
EPS NQ rev (1m)-28.57%
EPS NQ rev (3m)-20.45%
EPS NY rev (1m)-8.96%
EPS NY rev (3m)-2.03%
Revenue NQ rev (1m)-0.99%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.44 | ||
| Fwd PE | 8.72 | ||
| P/S | 1.06 | ||
| P/FCF | 17.51 | ||
| P/OCF | 16.47 | ||
| P/B | 3.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.49 |
EPS(TTM)0.5
EY6.93%
EPS(NY)0.83
Fwd EY11.47%
FCF(TTM)0.41
FCFY5.71%
OCF(TTM)0.44
OCFY6.07%
SpS6.82
BVpS1.95
TBVpS-2.82
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.02% | ||
| ROE | -0.1% | ||
| ROCE | 7.7% | ||
| ROIC | 6.08% | ||
| ROICexc | 6.49% | ||
| ROICexgc | 33.79% | ||
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 67.6% | ||
| FCFM | 6.04% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 10.3 | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 4.42% | ||
| Cap/Sales | 0.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 40.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.11 |
F-Score7
WACC8.57%
ROIC/WACC0.71
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
EPS Next Y38.25%
EPS Next 2Y32.75%
EPS Next 3Y23.03%
EPS Next 5YN/A
Revenue 1Y (TTM)5.07%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
Revenue Next Year0.06%
Revenue Next 2Y3.4%
Revenue Next 3Y4.09%
Revenue Next 5YN/A
EBIT growth 1Y188.15%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year17.28%
EBIT Next 3Y13.26%
EBIT Next 5YN/A
FCF growth 1Y336.04%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y103.28%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%